Phagocytes, Granulocytes, and Myelopoiesis: ST3GAL-4 is the primary sialyltransferase regulating the synthesis of E-, P-, and L-selectin ligands on human myeloid leukocytes

Blood

Volumn 125, Issue 4, 2015, Pages 687-696

  Mondal, Nandini ^a   Buffone, Alexander ^a   Stolfa, Gino ^a   Antonopoulos, Aristotelis ^b   Lau, Joseph T Y ^c   Haslam, Stuart M ^b   Dell, Anne ^b   Neelamegham, Sriram ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCAN DERIVATIVE; L SELECTIN; PADGEM PROTEIN; SHORT HAIRPIN RNA; SIALYLTRANSFERASE; ST3GAL 3 PROTEIN; ST3GAL 4 PROTEIN; ST3GAL 6 PROTEIN; UNCLASSIFIED DRUG; BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL DENSITY; CELL LINEAGE; CELL SURFACE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; ENZYME REGULATION; FLOW CYTOMETRY; GENE INACTIVATION; GENE SILENCING; GLYCOBIOLOGY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKOCYTE; LEUKOCYTE ROLLING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; MURINE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; CHO CELL LINE; CRICETULUS; CYTOLOGY; GENETICS; HAMSTER; HL 60 CELL LINE; METABOLISM; NEUTROPHIL; PHYSIOLOGY;

ANIMALS; CELL ADHESION; CHO CELLS; CRICETINAE; CRICETULUS; E-SELECTIN; GENE SILENCING; GLYCOMICS; HEMATOPOIETIC STEM CELLS; HL-60 CELLS; HUMANS; L-SELECTIN; LEUKOCYTE ROLLING; MICE; NEUTROPHILS; P-SELECTIN; SIALYLTRANSFERASES;

EID: 84921720492     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-07-588590     Document Type: Article

References (50)

1. Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev. 1999;79(1):181-213.
2. Beauharnois ME, Lindquist KC, Marathe D, et al. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and Pselectin. Biochemistry. 2005;44(27):9507-9519.
3. Simon SI, Green CE. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu Rev Biomed Eng. 2005;7:151-185.
4. Zarbock A, Ley K, McEver RP, Hidalgo A. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood. 2011;118(26):6743-6751.
5. Polley MJ, Phillips ML, Wayner E, et al. CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci USA. 1991;88(14):6224-6228.
6. Somers WS, Tang J, Shaw GD, Camphausen RT. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell. 2000;103(3):467-479.
7. Mondal N, Buffone A Jr, Neelamegham S. Distinct glycosyltransferases synthesize E-selectin ligands in human vs. mouse leukocytes. Cell Adhes Migr. 2013;7(3):288-292.
8. Buffone A Jr, Mondal N, Gupta R, McHugh KP, Lau JT, Neelamegham S. Silencing a1,3-fucosyltransferases in human leukocytes reveals a role for FUT9 enzyme during E-selectinmediated cell adhesion. J Biol Chem. 2013;288(3):1620-1633.
9. Larsen GR, Sako D, Ahern TJ, et al. P-selectin and E-selectin. Distinct but overlapping leukocyte ligand specificities. J Biol Chem. 1992;267(16):11104-11110.
10. Kobzdej MM, Leppänen A, Ramachandran V, Cummings RD, McEver RP. Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells. Blood. 2002;100(13):4485-4494.
11. Stroud MR, Handa K, Salyan ME, et al. Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin. Biochemistry. 1996;35(3):770-778.
12. Zöllner O, Lenter MC, Blanks JE, et al. L-selectin from human, but not from mouse neutrophils binds directly to E-selectin. J Cell Biol. 1997;136(3):707-716.
13. Sperandio M, Smith ML, Forlow SB, et al. P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med. 2003;197(10):1355-1363.
14. Levinovitz A, Mühlhoff J, Isenmann S, Vestweber D. Identification of a glycoprotein ligand for E-selectin on mouse myeloid cells. J Cell Biol. 1993;121(2):449-459.
15. Merzaban JS, Burdick MM, Gadhoum SZ, et al. Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells. Blood. 2011;118(7):1774-1783.
16. Hidalgo A, Peired AJ, Wild MK, Vestweber D, Frenette PS. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity. 2007;26(4):477-489.
17. Yago T, Fu J, McDaniel JM, Miner JJ, McEver RP, Xia L. Core 1-derived O-glycans are essential E-selectin ligands on neutrophils. Proc Natl Acad Sci USA. 2010;107(20):9204-9209.
18. Okajima T, Fukumoto S, Miyazaki H, et al. Molecular cloning of a novel α2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids. J Biol Chem. 1999;274(17):11479-11486.
19. Sasaki K, Watanabe E, Kawashima K, et al. Expression cloning of a novel Gal beta (1-3/1-4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection. J Biol Chem. 1993;268(30):22782-22787.
20. Kono M, Ohyama Y, Lee Y-C, Hamamoto T, Kojima N, Tsuji S. Mouse b-galactoside a 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression. Glycobiology. 1997;7(4):469-479.
21. Kitagawa H, Paulson JC. Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. J Biol Chem. 1994;269(2):1394-1401.
22. Miyamoto D, Takashima S, Suzuki T, et al. Glycolipid acceptor specificity of a human Gal beta(1-3/1-4) GlcNAc alpha 2,3-sialyltransferase. Biochem Biophys Res Commun. 1995;217(3):852-858.
23. Jeanneau C, Chazalet V, Augé C, et al. Structurefunction analysis of the human sialyltransferase ST3Gal I: role of n-glycosylation and a novel conserved sialylmotif. J Biol Chem. 2004;279(14):13461-13468.
24. Kim Y-J, Kim K-S, Kim S-H, et al. Molecular cloning and expression of human Gal β 1,3GalNAc α 2,3-sialytransferase (hST3Gal II). Biochem Biophys Res Commun. 1996;228(2):324-327.
25. Kono M, Takashima S, Liu H, et al. Molecular cloning and functional expression of a fifth-type α 2,3-sialyltransferase (mST3Gal V: GM3 synthase). Biochem Biophys Res Commun. 1998;253(1):170-175.
26. Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819-823.
27. Marathe DD, Chandrasekaran EV, Lau JT, Matta KL, Neelamegham S. Systems-level studies of glycosyltransferase gene expression and enzyme activity that are associated with the selectin binding function of human leukocytes. FASEB J. 2008;22(12):4154-4167.
28. Ellies LG, Sperandio M, Underhill GH, et al. Sialyltransferase specificity in selectin ligand formation. Blood. 2002;100(10):3618-3625.
29. Yang WH, Nussbaum C, Grewal PK, Marth JD, Sperandio M. Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands. Blood. 2012;120(5):1015-1026.
30. Gupta D, Shah HP, Malu K, Berliner N, Gaines P. Differentiation and characterization of myeloid cells. Curr Protoc Immunol. 2014;104:Unit 22F.5.
31. Hino M, Suzuki K, Yamane T, et al. Ex vivo expansion of mature human neutrophils with normal functions from purified peripheral blood CD341 haematopoietic progenitor cells. Br J Haematol. 2000;109(2):314-321.
32. Jang-Lee J, North SJ, Sutton-Smith M, et al. Glycomic profiling of cells and tissues by mass spectrometry: fingerprinting and sequencing methodologies. Methods Enzymol. 2006;415:59-86.
33. Ceroni A, Maass K, Geyer H, Geyer R, Dell A, Haslam SM. GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res. 2008;7(4):1650-1659.
34. Liu G, Neelamegham S. A computational framework for the automated construction of glycosylation reaction networks. PLoS ONE. 2014;9(6):e100939.
35. Lo CY, Antonopoulos A, Gupta R, et al. Competition between core-2 GlcNAc-transferase and ST6GalNAc-transferase regulates the synthesis of the leukocyte selectin ligand on human P-selectin glycoprotein ligand-1. J Biol Chem. 2013;288(20):13974-13987.
36. Snapp KR, Ding H, Atkins K, Warnke R, Luscinskas FW, Kansas GS. A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin. Blood. 1998;91(1):154-164.
37. Sperandio M, Frommhold D, Babushkina I, et al. α 2,3-sialyltransferase-IV is essential for L-selectin ligand function in inflammation. Eur J Immunol. 2006;36(12):3207-3215.
38. Nimrichter L, Burdick MM, Aoki K, et al. E-selectin receptors on human leukocytes. Blood. 2008;112(9):3744-3752.
39. Liu W, Ramachandran V, Kang J, Kishimoto TK, Cummings RD, McEver RP. Identification of N-terminal residues on P-selectin glycoprotein ligand-1 required for binding to P-selectin. J Biol Chem. 1998;273(12):7078-7087.
40. Ju T, Brewer K, D'Souza A, Cummings RD, Canfield WM. Cloning and expression of human core 1 beta1,3-galactosyltransferase. J Biol Chem. 2002;277(1):178-186.
41. Ellies LG, Tsuboi S, Petryniak B, Lowe JB, Fukuda M, Marth JD. Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity. 1998;9(6):881-890.
42. Asano M, Nakae S, Kotani N, et al. Impaired selectin-ligand biosynthesis and reduced inflammatory responses in beta-1,4-galactosyltransferase-I-deficient mice. Blood. 2003;102(5):1678-1685.
43. Malý P, Thall A, Petryniak B, et al. The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell. 1996;86(4):643-653.
44. Weninger W, Ulfman LH, Cheng G, et al. Specialized contributions by alpha(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Immunity. 2000;12(6):665-676.
45. Handa K, Stroud MR, Hakomori S. Sialosylfucosyl Poly-LacNAc without the sialosyl-Lex epitope as the physiological myeloid cell ligand in E-selectin-dependent adhesion: studies under static and dynamic flow conditions. Biochemistry. 1997;36(41):12412-12420.
46. Rillahan CD, Antonopoulos A, Lefort CT, et al. Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome. Nat Chem Biol. 2012;8(7):661-668.
47. Dimitroff CJ, Kupper TS, Sackstein R. Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen. J Clin Invest. 2003;112(7):1008-1018.
48. Marathe DD, Buffone A Jr, Chandrasekaran EV, et al. Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins. Blood. 2010;115(6):1303-1312.
49. Frommhold D, Ludwig A, Bixel MG, et al. Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation. J Exp Med. 2008;205(6):1435-1446.
50. Ellies LG, Ditto D, Levy GG, et al. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci USA. 2002;99(15):10042-10047.